At a glance
- Originator Roche
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Immunosuppressants; Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Graft-versus-host disease; Rheumatoid arthritis
Most Recent Events
- 31 Mar 1997 Preclinical development for Cancer in USA (Unknown route)
- 28 Jul 1995 Preclinical development for Graft-versus-host disease in United Kingdom (Unknown route)
- 28 Jul 1995 Preclinical development for Rheumatic disorders in United Kingdom (Unknown route)